40
Views
8
CrossRef citations to date
0
Altmetric
Miscellaneous

Antineoplastic agents 1998

&
Pages 1627-1672 | Published online: 25 Feb 2005
 

Abstract

This review will focus on the most recent patent-disclosed advances in identifying new potent drugs for cancer chemotherapy since the subject was last discussed in this journal in 1997, with the exception of fields that have been subsequently covered by other more focused reviews in the same journal.In particular we will summarise developments in the design and biochemical and pharmacological evaluation of novel antineoplastic agents belonging to the following classes: natural and fermentation products, DNA-targeted cytotoxic compounds, drugs for photodynamic therapy, non-taxane antimicrotubule agents, apoptosis modulators, enzymatic inhibitors, hormonal agents, multi-drug resistance reverters and antimetastatic drugs.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.